5195 — Bando Chemical Industries Balance Sheet
0.000.00%
- ¥91bn
- ¥74bn
- ¥119bn
Annual balance sheet for Bando Chemical Industries, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 20,304 | 19,146 | 21,545 | 20,757 | 22,367 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 22,740 | 23,092 | 23,854 | 23,828 | 23,499 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 59,200 | 60,470 | 63,556 | 63,396 | 68,332 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 32,954 | 32,521 | 32,545 | 30,532 | 32,653 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 116,381 | 118,971 | 125,622 | 120,693 | 131,892 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 28,520 | 32,169 | 32,458 | 31,292 | 33,583 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 44,247 | 41,314 | 40,458 | 38,561 | 39,284 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 72,134 | 77,657 | 85,164 | 82,132 | 92,608 |
| Total Liabilities & Shareholders' Equity | 116,381 | 118,971 | 125,622 | 120,693 | 131,892 |
| Total Common Shares Outstanding |